These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14263457)

  • 1. A COMPARISON OF THE PROCESSES OF IMMUNE HAEMOLYSIS AND ONCOLYSIS.
    HARTVEIT F
    J Pathol Bacteriol; 1965 Jan; 89():145-51. PubMed ID: 14263457
    [No Abstract]   [Full Text] [Related]  

  • 2. AN ANALYSIS OF THE REACTANTS IN THE ONCOLYTIC REACTION.
    HARTVEIT F
    J Pathol Bacteriol; 1965 Apr; 89():551-5. PubMed ID: 14320297
    [No Abstract]   [Full Text] [Related]  

  • 3. IMMUNITY TO TRANSPLANTABLE TUMORS FOLLOWING VIRAL ONCOLYSIS.II. ANTIGENIC SIMILARITIES BETWEEN THREE UNSPECIFIC MOUSE TUMORS.
    LINDENMANN J; KLEIN PA
    J Immunol; 1965 Mar; 94():461-6. PubMed ID: 14279800
    [No Abstract]   [Full Text] [Related]  

  • 4. [ON THE EFFECT OF 2-DESOXY-D-GLUCOSE ON EHRLICH ASCITES CARCINOMA].
    URBAHN H; SCHULZ J; KOENIG S; HOFMANN E
    Acta Biol Med Ger; 1964; 13():465-80. PubMed ID: 14274064
    [No Abstract]   [Full Text] [Related]  

  • 5. IMMUNITY TO TRANSPLANTABLE TUMORS FOLLOWING VIRAL ONCOLYSIS. I. MECHANISM OF IMMUNITY TO EHRLICH ASCITES TUMOR.
    LINDENMANN J
    J Immunol; 1964 Jun; 92():912-9. PubMed ID: 14218302
    [No Abstract]   [Full Text] [Related]  

  • 6. THE DEMONSTRATION OF AN INHIBITOR OF ONCOLYSIS IN THE ASCITIC FLUID FROM THE EHRLICH ASCITES CARCINOMA.
    HARTVEIT F
    Br J Cancer; 1964 Dec; 18(4):726-9. PubMed ID: 14264938
    [No Abstract]   [Full Text] [Related]  

  • 7. THE LYTIC ACTION OF FRESH HUMAN SERUM ON BERGEN A4 ASCITES CARCINOMA CELLS.
    HARTVEIT F
    Br J Cancer; 1964 Dec; 18(4):721-5. PubMed ID: 14264937
    [No Abstract]   [Full Text] [Related]  

  • 8. In-vitro potentiation of immune oncolysis by polyethylene glycol and by polyvinylpyrrolidone.
    Hartveit F
    J Pathol Bacteriol; 1967 Jul; 94(1):200-4. PubMed ID: 6053004
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of hemolysis by bivalent metal ions during virus-induced fusion of erythrocytes with Ehrlich ascites tumor cells.
    Zakai N; Loyter A; Kulka RG
    FEBS Lett; 1974 Apr; 40(2):331-4. PubMed ID: 4369039
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of monocyte and complement mediated haemolysis of human A1 erythrocytes: the relationship between antibody, target and effector concentrations in the induction of lysis.
    Bakács T; Tótpál K; Ringwald G; Yefenof E
    J Clin Lab Immunol; 1988 Feb; 25(2):53-8. PubMed ID: 3373517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of viability and maturation of human monocyte-derived dendritic cells by oncolytic adenoviruses.
    Schierer S; Hesse A; Müller I; Kämpgen E; Curiel DT; Schuler G; Steinkasserer A; Nettelbeck DM
    Int J Cancer; 2008 Jan; 122(1):219-29. PubMed ID: 17764070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LESIONS IN ERYTHROCYTE MEMBRANES CAUSED BY IMMUNE HAEMOLYSIS.
    BORSOS T; DOURMASHKIN RR; HUMPHREY JH
    Nature; 1964 Apr; 202():251-2. PubMed ID: 14167777
    [No Abstract]   [Full Text] [Related]  

  • 13. Altered erythrocyte osmotic fragility in mice with Ehrlich ascites tumor.
    Dumont AE; Nachbar MS; Martelli AB
    J Natl Cancer Inst; 1977 Sep; 59(3):989-91. PubMed ID: 894753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma.
    Boozari B; Mundt B; Woller N; Strüver N; Gürlevik E; Schache P; Kloos A; Knocke S; Manns MP; Wirth TC; Kubicka S; Kühnel F
    Gut; 2010 Oct; 59(10):1416-26. PubMed ID: 20675696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro potentiation of oncolysis by rheomacrodex.
    Hartveit F
    Acta Pathol Microbiol Scand; 1966; 66(1):51-4. PubMed ID: 5919483
    [No Abstract]   [Full Text] [Related]  

  • 16. MEASUREMENT OF IMMUNE CYTOLYSIS.
    ROMEYN JA; RIGBY C
    Nature; 1964 Mar; 201():1142-3. PubMed ID: 14152808
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of passive haemolysis in the quantitative estimation of anti-protein antibodies.
    Rangel H; Repka D
    Immunology; 1965 Jun; 8(6):618-27. PubMed ID: 5294634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9.
    Carney DF; Koski CL; Shin ML
    J Immunol; 1985 Mar; 134(3):1804-9. PubMed ID: 3968432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune haemolysis in agar: demonstration of the protective action of antibodies.
    Thompson RA; Rowe DS
    Immunology; 1967 Oct; 13(4):411-20. PubMed ID: 6055754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sendai virus haemolysis: mechanism of the increased haemolysis obtained by pretreatment of the virus with antibody and complement.
    Fadnes P; Haukenes G
    Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):223-7. PubMed ID: 225923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.